Trimethylammonium

Trimethylammonium

SCHEMBL4940105

CC(C)C(CN)C(C)C.CN(C)C

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1979 0.89
Ammonia Solution, Strong SCHEMBL6136995 0.86 ALDH1A1 (0.44) ALDH1A1
Bromide SCHEMBL1999327 0.86 ALDH1A1 (0.44) ALDH1A1
Hydrochloric Acid SCHEMBL366444 0.86 ALDH1A1 (0.44) ALDH1A1
Fluoride SCHEMBL1025918 0.86 ALDH1A1 (0.44) ALDH1A1
Fluoride SCHEMBL73856 0.86 ALDH1A1 (0.44) ALDH1A1
SCHEMBL4727402 0.86 ALDH1A1 (0.44) ALDH1A1
SCHEMBL3210302 0.86 ALDH1A1 (0.44) ALDH1A1
Dimethylformamide SCHEMBL277527 0.81 TSHR (0.45) ALDH1A1
SCHEMBL4787789 0.80 ALDH1A1 (0.39) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230390322-A1 HIGH CONCENTRATION METHYLCOBALAMIN OR COMBINATION OF METHYL- AND HYDROXY-COBALAMIN FOR THE TREATMENT OF COBALAMIN C DEFICIENCY DISORDERS THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-12-07 US disclosed
WO-2022081601-A1 HIGH CONCENTRATION METHYLCOBALAMIN OR COMBINATION OF METHYL- AND HYDROXY-COBALAMIN FOR THE TREATMENT OF COBALAMIN C DEFICIENCY DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2022-04-21 WO disclosed
US-20080039422-A1 Vitamin B12-Containing Compositions and Methods of Use TRANSITION THERAPEUTICS INC. (CA) 2008-02-14 US disclosed
WO-2003045969-A1 COUPLING REAGENT FOR H-PHOSPHONATE CHEMISTRY AVECIA BIOTECHNOLOGY INC. (US) 2003-06-05 WO disclosed